Legault, Daniel Marcel

Track

Insider profile

Performance

Overall performance
2.6
Performance over holding periods
2.6
30 days 90 days 120 days
Average return -12% 8.2% 15.1%
Success rate 66% 68% 82%
Transactions
2 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Legault, Daniel Marcel's trades of Antibe Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
63.65
Quantity 12,746 +18.4%
Value CA$4,810,090
Transaction date
Purchase
Price
138.62
Quantity 29,506 -32.5%
Value CA$1,368,846
Transaction date
Purchase
Price
381.27
Quantity 18,321 +1.0%
Value CA$2,025,323
Transaction date
Purchase
Price
0.62
Quantity 24,500 +2.8%
Value CA$15,190
Transaction date
Purchase
Price
0.60
Quantity 7,500 +0.9%
Value CA$4,500
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-03-07 2024-03-07
B Purchase
12,746 +18.4%
63.65
CA$4,810,090 		12,746 +18.4% 63.65 CA$4,810,090
2022-11-16 2022-11-15
B Purchase
29,506 -32.5%
138.62
CA$1,368,846 		29,506 -32.5% 138.62 CA$1,368,846
2022-07-12 2022-07-12
B Purchase
18,321 +1.0%
381.27
CA$2,025,323 		18,321 +1.0% 381.27 CA$2,025,323
2022-07-12 2022-07-11
B Purchase
24,500 +2.8%
0.62
CA$15,190 		24,500 +2.8% 0.62 CA$15,190
2022-07-12 2022-07-11
B Purchase
7,500 +0.9%
0.60
CA$4,500 		7,500 +0.9% 0.60 CA$4,500